Search clinical trials for: Growth Hormone
Total 62533 results
-
Eli Lilly and CompanyActive, not recruitingPancreatic Cancer | Solid Tumor | Cutaneous Melanoma | Microsatellite Instability-High (MSI-H) Solid Tumors | Breast Cancer (HR+HER2-)Belgium, Spain, Korea, Republic of, United States, Taiwan, France, Canada
-
National Cancer Institute (NCI)Active, not recruitingPrimary Effusion Lymphoma | B-Cell NeoplasmUnited States
-
Asociación para Evitar la Ceguera en MéxicoWithdrawnDiabetic RetinopathyMexico
-
Asociación para Evitar la Ceguera en MéxicoTerminatedProliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic RetinopathyMexico
-
Asociación para Evitar la Ceguera en MéxicoCentro Medico IssemymWithdrawnSubfoveal Choroidal NeovascularizationMexico
-
Asociación para Evitar la Ceguera en MéxicoWithdrawn
-
Asociación para Evitar la Ceguera en MéxicoTerminatedCentral Retinal Vein Occlusion | Macular EdemaMexico
-
Al-Azhar UniversityActive, not recruitingPeriapical Diseases | Growth Hormone | Non Surgical DebulkingEgypt
-
Universitätsklinikum Hamburg-EppendorfActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingNeuroendocrine Tumor | Neuroendocrine Neoplasm | Colorectal Neuroendocrine Tumor G1 | Gastric Neuroendocrine Tumor G1 | Neuroendocrine Tumor G2United States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
AbbVieRoche-GenentechActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, China, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Russian Federation, Singapore, Spain, Sweden, Turkey, Ukraine, United Kingdom
-
Janssen Research & Development, LLCCompletedMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, United Kingdom, France, Japan, Brazil
-
National Institute of Diabetes and Digestive and...CompletedHealthy VolunteersUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Japan, Canada, Netherlands, Denmark, Sweden, Korea, Republic of, Russian Federation, Greece
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited Kingdom, United States, France, Netherlands, Denmark
-
National Institute of Environmental Health Sciences...Enrolling by invitation
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Belgium, Germany, Netherlands, Israel, Spain, Saudi Arabia, France
-
Organon and CoCompletedHypogonadotropic HypogonadismBrazil, Denmark, Italy, Mexico, Russian Federation, South Africa
-
Carelon ResearchTerminatedCongenital Heart Disease | Hypoplastic Left HeartUnited States, Canada
-
Vejle HospitalActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
Novo Nordisk A/SEnrolling by invitationAdult Growth Hormone DeficiencyUnited States, Saudi Arabia, Germany, Slovenia
-
ImmunityBio, Inc.TerminatedPancreatic CancerUnited States
-
Novo Nordisk A/SActive, not recruitingGrowth Hormone Deficiency in ChildrenUnited States, Korea, Republic of, United Kingdom, Canada, Russian Federation, India, Spain, Italy, Algeria, Austria, France, Ireland, Israel, Japan, Latvia, Poland, Serbia, Thailand, Ukraine, Germany, Slovenia, Switzerland
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalCompleted
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaUnited States, Spain, United Kingdom, France, Australia, Canada
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v6United States, Puerto Rico
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Boston Scientific CorporationActive, not recruitingStroke | Atrial Fibrillation | BleedingUnited States, Australia, Denmark, Canada, Israel, United Kingdom, France, Belgium, Netherlands, Japan, Germany, Switzerland, Italy, Poland, Saudi Arabia, Spain
-
Hasselt UniversityHochschule Geisenheim UniversityCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Fallopian Tube Mucinous Adenocarcinoma and other conditionsUnited States, Korea, Republic of, Canada
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Ovarian Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Ovarian High Grade Serous Adenocarcinoma | Platinum-Resistant... and other conditionsUnited States, Canada
-
Ning JinActive, not recruitingMetastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8United States
-
National Cancer Institute (NCI)CompletedUrethral Neoplasms | Urethral Cancer | Neoplasms, Urethral | Cancer of the UrethraUnited States
-
PfizerActive, not recruitingBreast Cancer | Small Cell Lung Cancer | Ovarian CancerUnited States, China, Japan, Mexico, Bulgaria, Argentina
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
PfizerCompleted
-
Yale UniversityR-Pharm-US, LLCCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Hoffmann-La RocheActive, not recruitingPancreatic AdenocarcinomaUnited States, Spain, Korea, Republic of, Germany, Japan
-
University of LeedsCelgene; Janssen, LP; Myeloma UKActive, not recruiting